InventisBio Co., Limited (SHA:688382)
China · Delayed Price · Currency is CNY 25.87
-1.66 (-6.03%)
At close: Jan 22, 2026
InventisBio Revenue
InventisBio had revenue of 11.73M CNY in the quarter ending September 30, 2025, with 173.86% growth. This brings the company's revenue in the last twelve months to 180.53M, up 132.90% year-over-year. In the year 2024, InventisBio had annual revenue of 168.79M, down -9.02%.
Revenue (ttm)
180.53M
Revenue Growth
+132.90%
P/S Ratio
88.20
Revenue / Employee
975.82K
Employees
185
Market Cap
15.92B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 168.79M | -16.74M | -9.02% |
| Dec 31, 2023 | 185.53M | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | - | - | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Anhui Anke Biotechnology (Group) | 2.58B |
| Tibet Cheezheng Tibetan Medicine | 2.39B |
| Pacific Shuanglin Bio-pharmacy | 2.38B |
| Sinocelltech Group | 1.89B |
| Aurisco Pharmaceutical | 1.62B |
| Inner Mongolia Furui Medical Science | 1.47B |
| Jinyu Bio-technology | 1.33B |
| Mabwell (Shanghai) Bioscience | 624.52M |